靶区距离对垂体腺瘤立体定向放射外科治疗后垂体功能减退的影响
该研究纳入2007至2020年接受单次立体定向放射外科(SRS)治疗且随访≥6个月的224例垂体腺瘤成人患者,分析下丘脑-垂体轴与靶区距离和前叶垂体功能保留的关系。垂体腺中心与SRS靶区中心距离较大是功能保留的独立预测因子(OR 1.101,95%CI 1.000-1.213,p=0.050),随访时间较短亦与功能保留相关(OR 0.985,95%CI 0.977-0.993,p<0.0001)。作者认为增大正常垂体与靶区距离应成为腺瘤切除的目标,并需更大规模前瞻性多中心研究证实。
要点
- 垂体腺中心与SRS靶区中心距离较大是前叶垂体功能保留的独立预测因子(OR 1.101,95%CI 1.000-1.213,p=0.050)。
- 随访时间较短与功能保留相关(OR 0.985,95%CI 0.977-0.993,p<0.0001)。
- 最佳截断距离15 mm预测功能保留的敏感度30.0%、特异度88.0%、阳性预测值89.9%、阴性预测值26.2%。
核心结论
- 正常垂体与SRS靶区距离较大与前叶垂体功能保留相关,作者认为增大该距离应成为腺瘤切除的目标。
- 作者指出需要更大规模前瞻性多中心研究证实该发现并确立距离对SRS后垂体功能减退的影响。
研究设计与样本
- 2007至2020年连续纳入接受单次SRS治疗的非功能性或激素分泌性垂体腺瘤成人患者,随访≥6个月。
- 在MRI上量化下丘脑-垂体轴结构与SRS靶体积之间的距离,主要结局为前叶垂体功能保留。
- 采用多变量回归和受试者工作特征曲线下面积(AUROC)分析比较结局。
- 研究队列共224例,按SRS后前叶垂体功能保留(n=168)与未保留(n=56)分组。
- 平均临床随访53.7(38.0)个月,中位临床随访46.0(17.0-75.0)个月。
主要发现
- 前叶垂体功能保留的独立预测因子为垂体腺中心与SRS靶区中心距离较大(OR 1.101,95%CI 1.000-1.213,p=0.050)。
- 前叶垂体功能保留的另一独立预测因子为临床随访时间较短(OR 0.985,95%CI 0.977-0.993,p<0.0001)。
- 垂体腺中心与SRS靶区中心距离预测前叶垂体功能保留的校正AUROC为0.595。
- 最佳截断距离15 mm处预测前叶垂体功能保留的敏感度30.0%、特异度88.0%、阳性预测值89.9%、阴性预测值26.2%。
关键数值与推荐
- 垂体腺中心与SRS靶区中心距离每增加1个单位,前叶垂体功能保留的OR为1.101(95%CI 1.000-1.213,p=0.050)。
- 临床随访时间每增加1个单位,前叶垂体功能保留的OR为0.985(95%CI 0.977-0.993,p<0.0001)。
- 距离预测前叶垂体功能保留的校正AUROC为0.595。
- 最佳截断距离15 mm处敏感度30.0%、特异度88.0%、阳性预测值89.9%、阴性预测值26.2%。
临床怎么用
- 作者认为增大正常垂体与SRS靶区之间的距离应成为腺瘤切除的目标。
- 作者指出需要更大规模前瞻性多中心研究证实该发现并确立距离对SRS后垂体功能减退的影响。
局限性
- 作者指出需要更大规模前瞻性多中心研究证实该发现并确立距离对SRS后垂体功能减退的影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
INTRODUCTION: Delayed hypopituitarism is the most common complication after stereotactic radiosurgery (SRS) for pituitary adenomas. The aim of this study was to investigate the relationship between the distance from the hypothalamic-pituitary axis to the treatment target and anterior pituitary function preservation after SRS. METHODS: Between 2007 and 2020, consecutive adult patients who underwent single-session SRS for non-functioning or hormone-secreting pituitary adenomas with ≥ 6 months of follow-up were included. Distance measurements between hypothalamic-pituitary axis structures and the SRS target volume were quantified on MRI. The primary outcome was anterior pituitary function preservation. Outcomes were compared using multivariable regression and area under the receiver operator characteristic curve (AUROC) analyses. RESULTS: The study cohort comprised 224 patients, who were categorized by preservation (n = 168) and no preservation (n = 56) of anterior pituitary function after SRS. The mean and median clinical follow-up durations were 53.7 (38.0) and 46.0 (17.0-75.0) months, respectively. Independent predictors of anterior pituitary function preservation were a greater distance between the center of the pituitary gland and center of the SRS target [OR 1.101 (1.000-1.213), p = 0.050], and a shorter clinical follow-up duration [OR 0.985 (0.977-0.993), p < 0.0001]. The adjusted AUROC for the distance from the center of the pituitary gland and center of the SRS target in predicting anterior pituitary function preservation was 0.595. The sensitivity, specificity, positive predictive value and negative predictive value in predicting anterior pituitary function preservation at the optimal cut-off distance of 15 mm were 30.0, 88.0, 89.9 and 26.2%, respectively. CONCLUSIONS: Greater distance between the normal pituitary gland and the SRS target is associated with anterior pituitary function preservation and increasing this distance should be a goal of adenoma resection. Larger prospective, multi-center studies are necessary to corroborate this finding and establish the effects of distance on hypopituitarism after SRS for pituitary adenomas.
引用
- Ironside N, Snyder H, Xu Z, et al. Effect of distance from target on hypopituitarism after stereotactic radiosurgery for pituitary adenomas. J Neurooncol. 2022. PMID: 35461378. doi:10.1007/s11060-022-04007-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。